Unveiling the role of MicroRNA 155 in diffuse large B cell lymphoma.

被引：0
作者：
Rai, Deepak [1 ]
Karanti, Shailaja [1 ]
Dahia, Patricia [1 ]
Aguiar, Ricardo C. T. [1 ]
机构：
[1] Univ Texas, HSC, San Antonio, TX USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.2024.2024
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2024
引用
收藏
页码：573A / 573A
页数：1
相关论文
共 50 条
[41]   MICRORNA-155 CONTROLS VINCRISTINE SENSITIVITY AND PREDICTS SUPERIOR CLINICAL OUTCOME IN DIFFUSE LARGE B-CELL LYMPHOMA [J].
Due, H. ;
Schonherz, A. A. ;
Ryo, L. B. ;
Roug, A. S. ;
Johnsen, H. E. ;
Bogsted, M. ;
Mikkelsen, J. G. ;
Dybkaer, K. .
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 :12-12
[42]   Genetic evidence of evolution from diffuse to intravascular large B-cell lymphoma. [J].
Zhao, XF ;
Nowak, NJ ;
Conroy, JM ;
Bartos, JD ;
Anderson, GR ;
Sait, SN ;
Sands, AM ;
Barcos, MP .
BLOOD, 2001, 98 (11) :237B-238B
[43]   Alteration of RhoH expression is associated with human diffuse large B-cell lymphoma. [J].
Gu, Y ;
Alvares, CJ ;
Jasti, AC ;
Jansen, M ;
Bean, J ;
Jegga, AG ;
Aronow, BJ ;
Williams, DA .
BLOOD, 2004, 104 (11) :159B-159B
[44]   Cost-effectiveness of rituximab in treatment of diffuse large B-cell lymphoma. [J].
Coiffier, B ;
Best, JH ;
Omnes, LF ;
Hornberger, JC .
BLOOD, 2001, 98 (11) :864A-864A
[45]   Signatures of response to the proteasome inhibitor bortezomib in diffuse large B-cell lymphoma. [J].
Feuerhake, F ;
Monti, S ;
Blank, J ;
Wu, EX ;
Chen, W ;
Golub, TR ;
Shipp, MA .
BLOOD, 2005, 106 (11) :181A-181A
[46]   Prognostic analysis of aberrant somatic hypermutation of RhoH in diffuse large B cell lymphoma. [J].
Katsumi, Akira ;
Hiraga, Junji ;
Iwasaki, Toshihiro ;
Abe, Akihiro ;
Kiyoi, Hitoshi ;
Matsushita, Tadashi ;
Kinoshita, Tomohiro ;
Naoe, Tomoki .
BLOOD, 2006, 108 (11) :578A-578A
[47]   Surgical complications in patients treated with chemotherapy for gastric diffuse large B cell lymphoma. [J].
Spectre, G ;
Libster, D ;
Grisariu, S ;
Da'as, N ;
Gimmon, Z ;
Paltiel, O .
BLOOD, 2005, 106 (11) :263B-263B
[48]   Primary Splenic Diffuse Large B Cell Lymphoma. Case Report and Literature Review [J].
Hacer Berna Afacan Öztürk ;
Murat Albayrak ;
Çiğdem Pala ;
Abdulkerim Yıldız ;
Senem Maral ;
Osman Şahin ;
Pınar Cömert ;
Ünsal Han .
SN Comprehensive Clinical Medicine, 2020, 2 (11) :2448-2451
[49]   Significance of c-myc rearrangements in diffuse large B-cell lymphoma. [J].
Bierman, Philip ;
Loberiza, Fausto ;
Dave, Bhavana ;
Sanger, Warren ;
Bociek, R. Gregory ;
Bast, Martin ;
Vose, Julie M. ;
Armitage, James Olen ;
Weisenburger, Dennis .
BLOOD, 2006, 108 (11) :575A-575A
[50]   PRMT1 as a therapeutic target in diffuse large B-cell lymphoma. [J].
Goverdhan, Aarthi ;
Lee, Heng-Huan ;
Havranek, Ondrej ;
Davis, Richard Eric ;
Hung, Mien-Chie .
CLINICAL CANCER RESEARCH, 2017, 23 (24) :42-42
12345